NewsBite

Mayne wins FDA approval for oral contraceptive

Carrie LaFrenz
Carrie LaFrenzSenior reporter
EmailLinkedInTwitterFacebook

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Mayne Pharma has gained approval from the US Food and Drug Administration for a new application for its oral contraceptive Nextstellis, ahead of a launch in late June.

This is only the third time in history that an Australian company has received FDA approval for a new chemical entity. Mayne’s stock jumped by more than 15 per cent to 53¢ on the news, and had retreated to 50¢ by lunchtime on Friday.

Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
EmailLinkedInTwitterFacebook

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

License article

Read More

Latest In Healthcare & fitness

Fetching latest articles

Most Viewed In Companies

    Original URL: https://www.afr.com/companies/healthcare-and-fitness/mayne-wins-fda-approval-for-oral-contraceptive-20210416-p57jqi